years are americans or caribbean or latin american people going to be able to invest in the chikungunya vaccine. they have to think about the cost of developing and licensing the vaccine which typically costs in the hundreds of millions of dollars. in the case of chikungunya how would you test the vac teen in order to show that it protects people to have it licensed. so government needs to become involved. what we're starting to see with ebola we're also going to see with chikungunya. different groups of countries partnering with big pharma are going to have to develop a novel, innovative way to fund and get these vaccines to market. >> unless i missed my guess knowing a couple of people who have it will make money less of an object. amesh, scott thank thank you for being with us today. i'm ray suarez. >> coming up at 6:00 p.m. eastern. rebels in yemen attack the country's presidential palace. one official calls it an attempted coup. right now it's not known who controls the capitol. and charity groups sounding the alarm about wealth and equality with staggering new predictions. that and more c